Artesunate Tablet Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 165 Category: Pharma & Healthcare Report Code : HC0316292
Artesunate Tablet Market By Product Type (MonoaromaticArtesunate, Compound Artesunate) and Application (Hospital, Clinic, Other)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Artesunate Tablet Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Artesunate Tablet Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- FosunPharma (Guilin)
- Ipca Laboratories
- Sanofi Aventis
- Ajanta Pharma
- Shin Poong
- Cipla
- Acino
- MCW Healthcare
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Artesunate Tablet Market, ByProduct Type, Estimates and Forecast, 2017-2027 ($Million)
o MonoaromaticArtesunate
o Compound Artesunate
· Artesunate Tablet Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic
o Other
· Artesunate Tablet Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Fosun Pharma (Guilin)
o Ipca Laboratories
o Sanofi Aventis
o Ajanta Pharma
o Shin Poong
o Cipla
o Acino
o MCW Healthcare
· Artesunate Tablet Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Artesunate Tablet Market, By Country
o U.S. Artesunate Tablet Market
o Canada Artesunate Tablet Market
o Mexico Artesunate Tablet Market
§ Europe Artesunate Tablet Market, By Country
· Germany Artesunate Tablet Market
o UK Artesunate Tablet Market
o France Artesunate Tablet Market
o RussiaArtesunate Tablet Market
o Italy Artesunate Tablet Market
o Rest of Europe Artesunate Tablet Market
o Asia-Pacific
§ Asia-Pacific Artesunate Tablet Market, By Country
o ChinaArtesunate Tablet Market
o Japan Artesunate Tablet Market
o South KoreaArtesunate Tablet Market
o India Artesunate Tablet Market
o Southeast AsiaArtesunate Tablet Market
o Rest of Asia-Pacific Artesunate Tablet Market
o South America
§ South AmericaArtesunate Tablet Market
o Brazil Artesunate Tablet Market
o ArgentinaArtesunate Tablet Market
o ColumbiaArtesunate Tablet Market
o Rest of South America Artesunate Tablet Market
o Middle East and Africa
§ Middle East and AfricaArtesunate Tablet Market
o Saudi ArabiaArtesunate Tablet Market
o UAEArtesunate Tablet Market
o EgyptArtesunate Tablet Market
o NigeriaArtesunate Tablet Market
o South Africa Artesunate Tablet Market
o Rest of MEA Artesunate Tablet Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Artesunate Tablet Market, By Product Type
5.1. Introduction
5.2. Global Artesunate Tablet Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Artesunate Tablet Revenue and Revenue Share by Product Type (2017-2021)
5.3. Monoaromatic Artesunate
5.3.1. Global Monoaromatic Artesunate Revenue and Growth Rate (2017-2021)
5.4. Compound Artesunate
5.4.1. Global Compound Artesunate Revenue and Growth Rate (2017-2021)
6. Artesunate Tablet Market, By Application
6.1. Introduction
6.2. Global Artesunate Tablet Revenue and Market Share by Application (2017-2021)
6.2.1. Global Artesunate Tablet Revenue and Revenue Share by Application (2017-2021)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2021)
6.4. Clinic
6.4.1. Global Clinic Revenue and Growth Rate (2017-2021)
6.5. Other
6.5.1. Global Other Revenue and Growth Rate (2017-2021)
7. Artesunate Tablet Market, By Region
7.1. Introduction
7.2. Global Artesunate Tablet Revenue and Market Share by Regions
7.2.1. Global Artesunate Tablet Revenue by Regions (2017-2021)
7.3. North America Artesunate Tablet by Countries
7.3.1. North America Artesunate Tablet Revenue and Growth Rate (2017-2021)
7.3.2. North America Artesunate Tablet Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Artesunate Tablet by Countries
7.4.1. Europe Artesunate Tablet Revenue and Growth Rate (2017-2021)
7.4.2. Europe Artesunate Tablet Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Artesunate Tablet by Countries
7.5.1. Asia-Pacific Artesunate Tablet Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Artesunate Tablet Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Artesunate Tablet by Countries
7.6.1. South America Artesunate Tablet Revenue and Growth Rate (2017-2021)
7.6.2. South America Artesunate Tablet Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Artesunate Tablet by Countries
7.7.1. Middle East and Africa Artesunate Tablet Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Artesunate Tablet Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Fosun Pharma (Guilin)
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Ipca Laboratories
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Sanofi Aventis
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Ajanta Pharma
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Shin Poong
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Cipla
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Acino
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. MCW Healthcare
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Artesunate Tablet Market Forecast (2022-2027)
9.1. Global Artesunate Tablet Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Artesunate Tablet Market Forecast by Regions (2022-2027)
9.2.1. North America Artesunate Tablet Market Forecast (2022-2027)
9.2.1.1. United States Artesunate Tablet Market Forecast (2022-2027)
9.2.1.2. Canada Artesunate Tablet Market Forecast (2022-2027)
9.2.1.3. Mexico Artesunate Tablet Market Forecast (2022-2027)
9.2.2. Europe Artesunate Tablet Market Forecast (2022-2027)
9.2.2.1. Germany Artesunate Tablet Market Forecast (2022-2027)
9.2.2.2. France Artesunate Tablet Market Forecast (2022-2027)
9.2.2.3. UK Artesunate Tablet Market Forecast (2022-2027)
9.2.2.4. Russia Artesunate Tablet Market Forecast (2022-2027)
9.2.2.5. Italy Artesunate Tablet Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Artesunate Tablet Market Forecast (2022-2027)
9.2.3. Asia-Pacific Artesunate Tablet Market Forecast (2022-2027)
9.2.3.1. China Artesunate Tablet Market Forecast (2022-2027)
9.2.3.2. Japan Artesunate Tablet Market Forecast (2022-2027)
9.2.3.3. Korea Artesunate Tablet Market Forecast (2022-2027)
9.2.3.4. India Artesunate Tablet Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Artesunate Tablet Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Artesunate Tablet Market Forecast (2022-2027)
9.2.4. South America Artesunate Tablet Market Forecast (2022-2027)
9.2.4.1. Brazil Artesunate Tablet Market Forecast (2022-2027)
9.2.4.2. Argentina Artesunate Tablet Market Forecast (2022-2027)
9.2.4.3. Columbia Artesunate Tablet Market Forecast (2022-2027)
9.2.4.4. Rest of South America Artesunate Tablet Market Forecast (2022-2027)
9.2.5. Middle East and Africa Artesunate Tablet Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Artesunate Tablet Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Artesunate Tablet Market Forecast (2022-2027)
9.2.5.3. Egypt Artesunate Tablet Market Forecast (2022-2027)
9.2.5.4. Nigeria Artesunate Tablet Market Forecast (2022-2027)
9.2.5.5. South Africa Artesunate Tablet Market Forecast (2022-2027)
9.2.5.6. Turkey Artesunate Tablet Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Artesunate Tablet Market Forecast (2022-2027)
9.3. Artesunate Tablet Market Forecast by Product Type (2022-2027)
9.3.1. Artesunate Tablet Forecast by Product Type (2022-2027)
9.3.2. Artesunate Tablet Market Share Forecast by Product Type (2022-2027)
9.4. Artesunate Tablet Market Forecast by Application (2022-2027)
9.4.1. Artesunate Tablet Forecast by Application (2022-2027)
9.4.2. Artesunate Tablet Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Artesunate Tablet Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Artesunate Tablet Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Monoaromatic Artesunate Revenue and Growth Rate (2017-2019)
Figure Global Compound Artesunate Revenue and Growth Rate (2017-2019)
Table Global Artesunate Tablet Revenue and Revenue Share by Application (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Clinic Revenue and Growth Rate (2017-2019)
Figure Global Other Revenue and Growth Rate (2017-2019)
Table Global Artesunate Tablet Revenue by Regions (2017-2019)
Figure North America Artesunate Tablet Growth Rate (2017-2019)
Figure North America Artesunate Tablet Revenue and Growth Rate (2017-2019)
Figure North America Artesunate Tablet by Countries (2017-2019)
Figure North America Artesunate Tablet Revenue (Million USD) by Countries (2017-2019)
Figure United States Artesunate Tablet Growth Rate (2017-2019)
Figure United States Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Artesunate Tablet Growth Rate (2017-2019)
Figure Canada Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Artesunate Tablet Growth Rate (2017-2019)
Figure Mexico Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Artesunate Tablet Growth Rate (2017-2019)
Figure Europe Artesunate Tablet Revenue and Growth Rate (2017-2019)
Figure Europe Artesunate Tablet by Countries (2017-2019)
Figure Europe Artesunate Tablet Revenue (Million USD) by Countries (2017-2019)
Figure Germany Artesunate Tablet Growth Rate (2017-2019)
Figure Germany Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Artesunate Tablet Growth Rate (2017-2019)
Figure France Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Artesunate Tablet Growth Rate (2017-2019)
Figure UK Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Artesunate Tablet Growth Rate (2017-2019)
Figure Russia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Artesunate Tablet Growth Rate (2017-2019)
Figure Italy Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Artesunate Tablet Growth Rate (2017-2019)
Figure Rest of Europe Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Artesunate Tablet Growth Rate (2017-2019)
Figure Asia-Pacific Artesunate Tablet Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Artesunate Tablet by Countries (2017-2019)
Figure Asia-Pacific Artesunate Tablet Revenue (Million USD) by Countries (2017-2019)
Figure China Artesunate Tablet Growth Rate (2017-2019)
Figure China Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Artesunate Tablet Growth Rate (2017-2019)
Figure Japan Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Artesunate Tablet Growth Rate (2017-2019)
Figure Korea Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Artesunate Tablet Growth Rate (2017-2019)
Figure India Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Artesunate Tablet Growth Rate (2017-2019)
Figure Southeast Asia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Artesunate Tablet Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Artesunate Tablet Growth Rate (2017-2019)
Figure South America Artesunate Tablet Revenue and Growth Rate (2017-2019)
Figure South America Artesunate Tablet by Countries (2017-2019)
Figure South America Artesunate Tablet Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Artesunate Tablet Growth Rate (2017-2019)
Figure Brazil Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Artesunate Tablet Growth Rate (2017-2019)
Figure Argentina Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Artesunate Tablet Growth Rate (2017-2019)
Figure Columbia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Artesunate Tablet Growth Rate (2017-2019)
Figure Rest of South America Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Artesunate Tablet Growth Rate (2017-2019)
Figure Middle East and Africa Artesunate Tablet Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Artesunate Tablet by Countries (2017-2019)
Figure Middle East and Africa Artesunate Tablet Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Artesunate Tablet Growth Rate (2017-2019)
Figure Saudi Arabia Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Artesunate Tablet Growth Rate (2017-2019)
Figure United Arab Emirates Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Artesunate Tablet Growth Rate (2017-2019)
Figure Egypt Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Artesunate Tablet Growth Rate (2017-2019)
Figure Nigeria Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Artesunate Tablet Growth Rate (2017-2019)
Figure South Africa Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Artesunate Tablet Growth Rate (2017-2019)
Figure Turkey Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Artesunate Tablet Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Artesunate Tablet Revenue (Millions USD) and Growth Rate (2017-2019)
Table Fosun Pharma (Guilin) Artesunate Tablet Financial Overview
Table Ipca Laboratories Artesunate Tablet Financial Overview
Table Sanofi Aventis Artesunate Tablet Financial Overview
Table Ajanta Pharma Artesunate Tablet Financial Overview
Table Shin Poong Artesunate Tablet Financial Overview
Table Cipla Artesunate Tablet Financial Overview
Table Acino Artesunate Tablet Financial Overview
Table MCW Healthcare Artesunate Tablet Financial Overview
Figure Global Artesunate Tablet Revenue (Millions USD) and Growth Rate (2019-2027)
Table Artesunate Tablet Market Forecast by Regions (2019-2027)
Figure North America Artesunate Tablet Market Forecast (2019-2027)
Figure United States Artesunate Tablet Market Forecast (2019-2027)
Figure Canada Artesunate Tablet Market Forecast (2019-2027)
Figure Mexico Artesunate Tablet Market Forecast (2019-2027)
Figure Europe Artesunate Tablet Market Forecast (2019-2027)
Figure Germany Artesunate Tablet Market Forecast (2019-2027)
Figure France Artesunate Tablet Market Forecast (2019-2027)
Figure UK Artesunate Tablet Market Forecast (2019-2027)
Figure Russia Artesunate Tablet Market Forecast (2019-2027)
Figure Italy Artesunate Tablet Market Forecast (2019-2027)
Figure Rest of Europe Artesunate Tablet Market Forecast (2019-2027)
Figure Asia-Pacific Artesunate Tablet Market Forecast (2019-2027)
Figure China Artesunate Tablet Market Forecast (2019-2027)
Figure Japan Artesunate Tablet Market Forecast (2019-2027)
Figure Korea Artesunate Tablet Market Forecast (2019-2027)
Figure India Artesunate Tablet Market Forecast (2019-2027)
Figure Southeast Asia Artesunate Tablet Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Artesunate Tablet Market Forecast (2019-2027)
Figure South America Artesunate Tablet Market Forecast (2019-2027)
Figure Brazil Artesunate Tablet Market Forecast (2019-2027)
Figure Argentina Artesunate Tablet Market Forecast (2019-2027)
Figure Columbia Artesunate Tablet Market Forecast (2019-2027)
Figure Rest of South America Artesunate Tablet Market Forecast (2019-2027)
Figure Middle East and Africa Artesunate Tablet Market Forecast (2019-2027)
Figure Saudi Arabia Artesunate Tablet Market Forecast (2019-2027)
Figure United Arab Emirates Artesunate Tablet Market Forecast (2019-2027)
Figure Egypt Artesunate Tablet Market Forecast (2019-2027)
Figure Nigeria Artesunate Tablet Market Forecast (2019-2027)
Figure South Africa Artesunate Tablet Market Forecast (2019-2027)
Figure Turkey Artesunate Tablet Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Artesunate Tablet Market Forecast (2019-2027)
Figure Global Artesunate Tablet Forecast by Product Type (2019-2027)
Figure Global Artesunate Tablet Market Share Forecast by Product Type (2019-2027)
Figure Global Artesunate Tablet Forecast by Product Type (2019-2027)
Figure Global Artesunate Tablet Forecast by Application (2019-2027)
Figure Global Artesunate Tablet Market Share Forecast by Application (2019-2027)
Figure Global Artesunate Tablet Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|